Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics of Midazolam”

238 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 238 results

Early research (Phase 1)Looking for participantsNCT07372625
What this trial is testing

Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

Who this might be right for
TP53 Y220C MutationAdvanced Solid Tumors
PMV Pharmaceuticals, Inc 14
Early research (Phase 1)Study completedNCT05492318
What this trial is testing

Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity

Who this might be right for
Drug-Drug InteractionHeathy Volunteer
Italfarmaco 26
Early research (Phase 1)Study completedNCT01768273
What this trial is testing

Evaluation of the Pharmacokinetic Interaction Between PA-824 and Midazolam

Who this might be right for
Tuberculosis
Global Alliance for TB Drug Development 14
Early research (Phase 1)Ended earlyNCT02182401
What this trial is testing

Multiple Doses of BI 207127 NA, BI 201335 NA Followed by the Combination of BI 207127 NA and BI 201335 NA in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 37
Early research (Phase 1)Study completedNCT02233244
What this trial is testing

Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam

Who this might be right for
Healthy
Celtaxsys, Inc. 20
Early research (Phase 1)Study completedNCT04187456
What this trial is testing

A Study in Healthy Male Subjects to Understand How Savolitinib When Taken With Midazolam Behaves Inside the Body

Who this might be right for
Solid Tumors
AstraZeneca 14
Early research (Phase 1)Study completedNCT06360211
What this trial is testing

Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants

Who this might be right for
Advanced Non-small Cell Lung CancerEGFR MutationHER2 Mutation+1 more
Bayer 15
Early research (Phase 1)Study completedNCT03762928
What this trial is testing

ESTIMATION OF THE EFFECT OF MULTIPLE DOSE PF-06651600 ON THE PHARMACOKINETICS OF SINGLE DOSE MIDAZOLAM AND EFAVIRENZ

Who this might be right for
Healthy Subjects
Pfizer 12
Early research (Phase 1)Study completedNCT02520752
What this trial is testing

A DDI Study to Assess the Effect of INC280 on the PK of Midazolam and Caffeine in Patients With cMET-dysregulated Advanced Solid Tumors

Who this might be right for
cMET-dysregulated Advanced Solid Tumors
Novartis Pharmaceuticals 37
Early research (Phase 1)Study completedNCT01827540
What this trial is testing

Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam

Who this might be right for
HIV-infection/AIDS
Tobira Therapeutics, Inc. 20
Early research (Phase 1)Study completedNCT05395117
What this trial is testing

Assess the Effect of AZD5462 on the Pharmacokinetics of Midazolam, Rosuvastatin and Digoxin

Who this might be right for
Healthy Participants
AstraZeneca 32
Early research (Phase 1)Study completedNCT06092931
What this trial is testing

A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants

Who this might be right for
Healthy Participants
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 28
Early research (Phase 1)Study completedNCT01209039
What this trial is testing

A Repeat Dose Positron Emission Tomography Study With GSK1144814

Who this might be right for
Schizophrenia
GlaxoSmithKline 41
Early research (Phase 1)Study completedNCT05254548
What this trial is testing

Investigate the Effect of Single and Repeated Oral Doses of ACT-539313 on What the Body Does to Flurbiprofen, Omeprazole, Midazolam in Healthy Subjects

Who this might be right for
Healthy
Idorsia Pharmaceuticals Ltd. 22
Early research (Phase 1)Study completedNCT01405612
What this trial is testing

Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy Volunteers

Who this might be right for
Digestive System Disorders
Norgine 14
Early research (Phase 1)Study completedNCT04275115
What this trial is testing

Effects of Repeated Doses of Foliglurax on Drug Metabolizing Enzymes in Healthy Subjects

Who this might be right for
Healthy
H. Lundbeck A/S 20
Early research (Phase 1)Study completedNCT01937260
What this trial is testing

Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 31
Early research (Phase 1)Study completedNCT01925911
What this trial is testing

Phase 1 Study in Healthy Subjects to Evaluate the Effect of IPI-145 on the Pharmacokinetics of Midazolam

Who this might be right for
Healthy
SecuraBio 14
Early research (Phase 1)Study completedNCT02686164
What this trial is testing

Phase 1 Study to Determine the Effect of Lenvatinib (E7080) on the Pharmacokinetics of Midazolam in Subjects With Advanced Solid Tumors

Who this might be right for
Tumors
Eisai Inc. 51
Early research (Phase 1)Study completedNCT03174041
What this trial is testing

A Drug-Drug Interaction Study Between GDC-0853 and Midazolam, Itraconazole, Rosuvastatin, and Simvastatin

Who this might be right for
Healthy Participants
Genentech, Inc. 63
Next Page